Prospective Clinical Study Showed the myRisk Test Identified 70 Percent More Deleterious Mutations than BRCA Testing Alone with 42 Percent of These in Women Over Age 45.
Read moreEl proyecto, en que participa la Dra. Cristina Cruz Zambrano del VHIO, investiga nuevas alternativas terapéuticas para aquellas mujeres con cáncer de mama que pese al tratamiento sufren una recaída...
Read moreLa jornada que tendrá lugar el próximo 26 y 27 de mayo en Barcelona, debatirá sobre las capacidades y limitaciones de los modelos preclínicos actuales. Nature Reviews Cancer serà el patrocinador ...
Read moreUn estudio realizado en pacientes con tumores gastrointestinales ha revelado la presencia en suero de anticuerpos contra el anisakis, a pesar de que nunca habían experimentado síntomas de la i...
Read moreThe group of Translational Research in Child and Adolescent Cancer, led by Dr. Josep Sanchez de Toledo and Dr. Soledad Gallego in the Vall d'Hebron Research Institute (VHIR), has identified a microRNA...
Read moreThe detection of TMPRSS2-ERG in the blood of patients with resistant metastatic prostate cancer predicts resistance to taxanes, such as docetaxel, and may be useful for selecting the best treatment op...
Read moreBajo el título “The Ubiquitin Proteolytic System: From Basic Mechanisms through Human Diseases and on to Drug Targeting”, el ganador del Premio Nobel de Química (2004), Aaron Ciechanover, resumi...
Read moreThe findings of a study published in the International Journal of Cancer and coordinated by researchers at CREAL, an allied ISGlobal centre, suggest an association between the risk of colorectal cance...
Read moreCollectively, these results provide a basis for the continued development of EC-8042 as an EWS-FLI1 inhibitor for the clinic, and highlights the therapeutic opportunities offered by targeting transcri...
Read moreIn an article published in Nature Communications, scientists at IRB Barcelona reveal that breast cancer cells require fatty acids from the extracellular environment in order to continue proliferating....
Read moreEl VI Curso de Cirugía de Cáncer de Mama del Hospital Universitario de Bellvitge estará dedicado a la redefinición de la extensión de la cirugía.
Read moreEl galardón de la EASL constituye un reconocimiento a la labor del BCLC Group, dedicado a la investigación clínica y traslacional en cáncer de hígado, que acaba de cumplir 30 años de existencia....
Read more